Growing Global Aging Will Expand Noninvasive Treatment Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
10 Aug 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
US$10.00
68.0% undervalued intrinsic discount15 Aug
US$3.20
1Y
-54.0%7D
-2.1%